These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6528586)

  • 21. Decrease of plasma large, light LDL (LDL1), HDL2 and HDL3 levels with concomitant increase of cholesteryl ester transfer protein (CETP) activity by probucol in type II hyperlipoproteinemia.
    Homma Y; Kobayashi T; Yamaguchi H; Sakane H; Ozawa H; Matsuda M; Mikami Y; Mikami Y; Nakamura H
    Artery; 1993; 20(1):1-18. PubMed ID: 8447724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet function in familial hypercholesterolaemia in South Africa and the effects of probucol.
    Bradlow BA; Chetty N; Birnbaum M; Baker SG; Seftel HC
    Thromb Res; 1982 Apr; 26(2):91-9. PubMed ID: 6214040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Probucol and familial hypercholesterolemia.
    Dauignon J; Bouthillier D
    Can Med Assoc J; 1982 May; 126(9):1024-5. PubMed ID: 7074497
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of probucol on plasma cholesterol, high and low density lipoprotein cholesterol, and apolipoproteins A1 and A2 in adults with primary familial hypercholesterolemia.
    Mellies MJ; Gartside PS; Glatfelter L; Vink P; Guy G; Schonfeld G; Glueck CJ
    Metabolism; 1980 Oct; 29(10):956-64. PubMed ID: 6999291
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment with probucol of children with familial hypercholesterolaemia.
    Sanjurjo P; Martul P; Sasieta M; Lafuente P; Ariza F; Cabeza I
    Acta Paediatr Scand; 1988 Jan; 77(1):132-5. PubMed ID: 3285634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. One year experience with probucol, a new hypocholesterolaemic agent.
    Ng AS; Johan A; Quek SS; Tan IK
    Singapore Med J; 1982 Aug; 23(4):191-3. PubMed ID: 7178901
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of combined probucol-colestipol treatment for familial hypercholesterolemia and coronary artery disease.
    Kuo PT; Wilson AC; Kostis JB; Moreyra AE
    Am J Cardiol; 1986 Jun; 57(16):43H-48H. PubMed ID: 3524177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of probucol on the cholesterol content of skin in type II hyperlipoproteinemias.
    Beaumont JL; Jacotot B; Buxtorf JC; Silvestre M; Beaumont V
    Artery; 1982; 10(1):71-87. PubMed ID: 7092577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cholesterol and triglyceride plasma levels in patients with primary hyperlipoproteinemia. Decline after short-term i.v. glucagon administration].
    Andĕl M; Brodan V; Kucerová L; Grafnetter D; Kuhn E; Veselková A
    Cas Lek Cesk; 1980 May; 119(22):616-21. PubMed ID: 7427980
    [No Abstract]   [Full Text] [Related]  

  • 30. Probucol and high-density-lipoprotein cholesterol.
    Gagné C; Lupien PJ; Brun D; Moorjani S; Toussaint M
    Can Med Assoc J; 1980 Sep; 123(5):356. PubMed ID: 7260778
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of probucol on blood lipids].
    Santos Rde O; Moriguchi Y
    Arq Bras Cardiol; 1982 Jul; 39(1):59-61. PubMed ID: 6762872
    [No Abstract]   [Full Text] [Related]  

  • 32. Probucol, a new cholesterol lowering drug.
    Nash DT
    J Med; 1975; 6(5-6):305-15. PubMed ID: 768396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hypolipidemic effects of DH581 during prolonged administration (author's transl)].
    Nash DT
    G Ital Cardiol; 1976; 6(3):550-5. PubMed ID: 1010207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of probucol on the composition and in vitro catabolism of LDL in type IIa hypercholesterolemia.
    Baudet MF; Esteva O; Dachet C; Jacotot B
    Atherosclerosis; 1986 Oct; 62(1):65-71. PubMed ID: 3778575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Action of probucol in the control of hypercholesterolemia].
    Quintão EC; Maranhão RC
    Arq Bras Cardiol; 1980 Apr; 34(4):331-3. PubMed ID: 7002123
    [No Abstract]   [Full Text] [Related]  

  • 36. Double-blind, placebo-controlled, cross-over trial of probucol in heterozygous familial hypercholesterolaemia.
    Durrington PN; Miller JP
    Atherosclerosis; 1985 May; 55(2):187-94. PubMed ID: 3890872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of probucol and cholestyramine combination therapy in severe familial hypercholesterolaemia.
    Jackson JM; Lee HA
    Atherosclerosis; 1984; 51(2-3):189-97. PubMed ID: 6743378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of probucol on triton induced hyperlipidemias in CFY rats.
    Krishnamurthy A; Thapar GS; Shridhar DR
    Artery; 1985; 13(2):87-94. PubMed ID: 4084069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparison of the lipid-lowering agents clofibrate and bezafibrate in patients with hyperlipoproteinemias IIa and IIb].
    Kokot F; Szczechowska E
    Z Gesamte Inn Med; 1981 Jul; 36(13):454-7. PubMed ID: 7025475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of probucol in hyperlipidemic patients during two years of administration.
    Parsons WB
    Am Heart J; 1978 Aug; 96(2):213-7. PubMed ID: 354360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.